Relay Therapeutics, Inc.RLAYNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -100.00% | +0.00% | -23.26% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | -23.26% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +14.72% | +36.52% | +29.34% | +28.94% | +22.93% |
| Weighted Average Shares Diluted Growth | +14.72% | +36.52% | +29.34% | +28.94% | +22.93% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +2.55% | +3.24% | -5.00% | -5.66% | -27.97% |
| Book Value per Share Growth | -6.06% | -24.24% | -25.24% | -24.28% | -41.07% |
| Debt Growth | -8.76% | -9.28% | -9.84% | -33.10% | -33.09% |
| R&D Expense Growth | -5.98% | -12.16% | -10.43% | -30.54% | -10.91% |
| SG&A Expenses Growth | +6.84% | +0.82% | -5.35% | -32.34% | -42.37% |